Published in Transplantation on October 27, 1997
Imbalance of regulatory T cells in human autoimmune diseases. Immunology (2006) 1.64
Induction of transplantation tolerance in non-human primate preclinical models. Philos Trans R Soc Lond B Biol Sci (2005) 1.02
Infectious tolerance to ADP/ATP carrier peptides induced by anti-L3T4 monoclonal antibody in dilated cardiomyopathy mice. J Clin Immunol (2005) 0.79
New rat model of Pneumocystis pneumonia induced by anti-CD4(+) T-lymphocyte antibodies. Infect Immun (2003) 0.77
Regulation of polar auxin transport by AtPIN1 in Arabidopsis vascular tissue. Science (1998) 7.95
MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat Cell Biol (1999) 5.75
Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med (1997) 5.19
Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol (2001) 3.76
Interleukin-10 therapy--review of a new approach. Pharmacol Rev (2003) 3.51
Structure of the Tet repressor-tetracycline complex and regulation of antibiotic resistance. Science (1994) 3.49
CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci U S A (1999) 3.07
Maternal seafood diet, methylmercury exposure, and neonatal neurologic function. J Pediatr (2000) 3.03
Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet (1999) 3.01
Migration patterns of dendritic cells in the mouse. Homing to T cell-dependent areas of spleen, and binding within marginal zone. J Exp Med (1988) 2.98
Genomic RNA of the murine coronavirus JHM. J Gen Virol (1978) 2.78
Country profile: Germany. Lancet (1996) 2.77
Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med (1999) 2.74
Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol (2000) 2.66
T-cell epitope mapping by flow cytometry. Nat Med (1998) 2.56
Target structures of the CD8(+)-T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited. J Virol (1999) 2.55
CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med (1995) 2.48
Barriers to xenotransplantation. Nat Med (1995) 2.44
Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells. Leukemia (2008) 2.44
A binary vector for transferring genomic libraries to plants. Nucleic Acids Res (1986) 2.34
Effect of filgrastim treatment on inflammatory cytokines and lymphocyte functions. Clin Pharmacol Ther (1999) 2.33
Expression of CD68 in non-myeloid cell types. Scand J Immunol (2008) 2.32
Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med (1998) 2.30
Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease. Mol Microbiol (1996) 2.30
Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease. Ann Neurol (2000) 2.30
Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides. Eur J Immunol (2000) 2.29
Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest (1999) 2.29
Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation (2000) 2.18
The association of workflow interruptions and hospital doctors' workload: a prospective observational study. BMJ Qual Saf (2011) 2.13
Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection. Nat Immunol (2001) 2.10
A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state. J Clin Invest (1998) 2.08
Biodiversity information platforms: From standards to interoperability. Zookeys (2011) 2.03
Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta. J Exp Med (1995) 2.03
Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J Immunol (2000) 1.95
A novel biologically active seleno-organic compound--I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (Ebselen). Biochem Pharmacol (1984) 1.90
Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis. J Clin Invest (1999) 1.84
Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs. Int Immunol (1995) 1.81
Quantum oscillations in a molecular magnet. Nature (2008) 1.79
Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience (2008) 1.75
Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation. Am J Transplant (2011) 1.71
[Rehabilitation and outpatient physiotherapy in rheumatic disease patients. Results of cross-sectional studies of patients with rheumatoid arthritis or ankylosing spondylitis and rheumatologists]. Z Rheumatol (2008) 1.67
Conserved outer membrane protein of Neisseria meningitidis involved in capsule expression. Infect Immun (1992) 1.67
Molecular analysis of the biosynthesis pathway of the alpha-2,8 polysialic acid capsule by Neisseria meningitidis serogroup B. Mol Microbiol (1994) 1.66
Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer. J Exp Med (1991) 1.66
Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer. Am J Pathol (1998) 1.65
Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis. Infect Immun (1997) 1.65
Systemic inflammation in patients with heart failure. Eur Heart J (1998) 1.64
Late-acute renal allograft rejection and symptomless cytomegalovirus infection. Lancet (1995) 1.63
Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol (1997) 1.63
Cyclic adenosine monophosphate-responsive elements are involved in the transcriptional activation of the human IL-10 gene in monocytic cells. Eur J Immunol (1999) 1.63
Loss of ATP diphosphohydrolase activity with endothelial cell activation. J Exp Med (1997) 1.62
Distribution of human CMV-specific memory T cells among the CD8pos. subsets defined by CD57, CD27, and CD45 isoforms. Eur J Immunol (1999) 1.62
Assessment of acute mountain sickness by different score protocols in the Swiss Alps. Aviat Space Environ Med (1998) 1.60
Cytokine profiles in Wegener's granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammation. Arthritis Rheum (1999) 1.59
Toxic effects of cyclosporine on the endocrine pancreas of Wistar rats. Transplantation (1986) 1.59
Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood (2000) 1.58
Postoperative complications after laparoscopic incisional hernia repair. Incidence and treatment. Surg Endosc (2002) 1.58
Isolation and characterization of Nicotiana plumbaginifolia nitrate reductase-deficient mutants: genetic and biochemical analysis of the NIA complementation group. Mol Gen Genet (1987) 1.56
Cytomegalovirus reactivation and tumour necrosis factor. Lancet (1994) 1.55
The Arabidopsis thaliana ABC transporter AtMRP5 controls root development and stomata movement. EMBO J (2001) 1.53
Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood (1995) 1.52
Phospholipid substitution of capsular polysaccharides and mechanisms of capsule formation in Neisseria meningitidis. Mol Microbiol (1993) 1.52
[Metabolic products of microorganisms. 61. Ferribactin, a siderochrome from Pseudomonas fluorescens Migula]. Arch Mikrobiol (1968) 1.52
Light-intensity dependence of the in vivo fluorescence lifetime of chlorophyll. Photochem Photobiol (1969) 1.51
Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad Sci U S A (1996) 1.51
Molecular techniques for detection, species differentiation, and phylogenetic analysis of microsporidia. Clin Microbiol Rev (1999) 1.50
Microsporidiosis: human diseases and diagnosis. Microbes Infect (2001) 1.50
Major challenges limiting liver transplantation in the United States. Am J Transplant (2011) 1.50
Antigenic heterogeneity of human mononuclear phagocytes: immunohistologic analysis using monoclonal antibodies. Blood (1983) 1.48
Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4. Br J Cancer (2006) 1.48
Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation. Am J Transplant (2008) 1.47
Clear lens extraction to correct high myopia. J Cataract Refract Surg (1996) 1.47
Prolonged discordant xenograft survival and delayed xenograft rejection in a pig-to-baboon orthotopic cardiac xenograft model. J Thorac Cardiovasc Surg (1998) 1.46
Angiotensin II receptor blocker induced fetopathy: 7 cases. Klin Padiatr (2011) 1.46
Microsurgical anatomy of the lateral approach to extraforaminal lumbar disc herniations. Neurosurgery (1996) 1.46
The relation between prompt and delayed emission in photosynthesis. Proc Natl Acad Sci U S A (1965) 1.45
Immunomodulatory therapies in sepsis. Intensive Care Med (2000) 1.45
Collagen crosslinks in fibromyalgia. Arthritis Rheum (1997) 1.44
Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection. J Clin Invest (2000) 1.44
Epithelial cells infected with Chlamydophila pneumoniae (Chlamydia pneumoniae) are resistant to apoptosis. Infect Immun (2001) 1.43
Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance induction. Transplantation (2000) 1.43
A novel class of oxylipins, sn1-O-(12-oxophytodienoyl)-sn2-O-(hexadecatrienoyl)-monogalactosyl Diglyceride, from Arabidopsis thaliana. J Biol Chem (2001) 1.43
Heavy chain ferritin acts as an antiapoptotic gene that protects livers from ischemia reperfusion injury. FASEB J (2003) 1.42
Role of indoleamine 2,3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines. Curr Drug Metab (2007) 1.42
Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection. Circulation (2001) 1.42
Extracellular matrix proteins in organ transplantation. Transplantation (2000) 1.41
[Inverted papilloma and its association with human papillomavirus (HPV). A study with polymerase chain reaction (PCR)]. HNO (1994) 1.40
The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137. Immunity (2000) 1.40
IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. J Clin Invest (1998) 1.40
Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester. J Immunol (1994) 1.40
Temporal modulation of an autoprotease is crucial for replication and pathogenicity of an RNA virus. J Virol (2004) 1.39
Quantitation of the octadecanoid 12-oxo-phytodienoic acid, a signalling compound in plant mechanotransduction. Phytochemistry (1998) 1.39
Verrucosis of hands and feet in a patient with combined immune deficiency. J Am Acad Dermatol (1997) 1.39
Photoexcitation of a volume plasmon in C60 ions. Phys Rev Lett (2005) 1.39
[Correlation between chronic hyperplastic laryngitis and infection with human papillomaviruses]. HNO (1993) 1.38